(Q67677221)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701813%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

TNF in pathophysiology: biosynthetic regulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701813%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

TNF in Pathophysiology: Biosynthetic Regulation (English)

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

2 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

2 November 2022

author name string

B. Beutler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1701813

2 November 2022

language of work or name

English

0 references

publication date

1 December 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701813%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.elsevier.com/content/article/PII:S0022202X9091195H?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

https://api.elsevier.com/content/article/PII:S0022202X9091195H?httpAccept=text/plain

2 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Journal of Investigative Dermatology

2 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701813%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701813%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

81S-84S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701813%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

6 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701813%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1111/1523-1747.ep12874797

16 September 2019

exact match

0 references

cites work

Shock and tissue injury induced by recombinant human cachectin

1

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

2 November 2022

2

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Tumors secreting human TNF/cachectin induce cachexia in mice

2 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor).

2 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Cachectin and tumour necrosis factor as two sides of the same biological coin

2 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

2 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

2 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection

2 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Tumor necrosis factor and disease severity in children with falciparum malaria.

2 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

2 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock

2 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

The production of a cytotoxic factor by mouse peritoneal macrophages and macrophage hybridomas treated with various stimulating agents

2 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Role of first stimulating agents in the production of tumor necrosis factor

2 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Macrophages from Babesia and malaria infected mice are primed for monokine release

2 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Characterization of macrophage function in Mycobacterium lepraemurium-infected mice: sensitivity of mice to endotoxin and release of mediators and lysosomal enzymes after endotoxin treatment

2 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity

2 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization

2 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

2 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Tumour necrosis factor and lymphotoxin genes map close to H–2D in the mouse major histocompatibility complex

2 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

TNF-alpha gene polymorphisms in type 1 (insulin-dependent) diabetes mellitus

2 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

2 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Nucleotide sequence of the murine TNF locus, including the TNF-alpha (tumor necrosis factor) and TNF-beta (lymphotoxin) genes

2 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Endotoxin-induced cytokine gene expression in vivo. I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia

2 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals

2 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators

2 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Posttranscriptional gene regulation and specific binding of the nonhistone protein HMG-I by the 3' untranslated region of bovine interleukin 2 cDNA.

2 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

2 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3' AU-rich sequences

2 November 2022

29

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Evolution of the genome and the genetic code: selection at the dinucleotide level by methylation and polyribonucleotide cleavage

2 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

The 3' untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation

2 November 2022

31

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Identification of a translation inhibitory element (TIE) in the 3' untranslated region of the human interferon-beta mRNA

2 November 2022

32

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Translational blockade imposed by cytokine-derived UA-rich sequences.

2 November 2022

33

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level

2 November 2022

34

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype

2 November 2022

35

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

Lps Gene-Associated Functions

2 November 2022

36

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12874797

2 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1701813%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

16 September 2019

0 references

1 reference